Pharming Group N.V. (PHAR)
NASDAQ: PHAR
· Real-Time Price · USD
11.75
0.37 (3.25%)
At close: Aug 15, 2025, 3:50 PM
11.60
-1.28%
After-hours: Aug 15, 2025, 05:26 PM EDT
Pharming Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Aug 5, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 341.2M | 320.86M | 297.35M | 286.55M | 278.14M | 259.01M | 245.97M | 218.72M | 206.3M | 201.55M | 205.62M | 196.75M | 191.95M | 191.55M | 187.18M | 211.67M | 220.75M | 216.28M |
Cost of Revenue | 36.47M | 35.35M | 35.39M | 37.95M | 39.43M | 37.16M | 32.87M | 24.37M | 18.45M | 16.76M | 17.56M | 16.18M | 19.44M | 20.07M | 19.89M | 23.09M | 23.61M | 24.09M |
Gross Profit | 304.52M | 285.3M | 261.62M | 248.25M | 238.58M | 221.72M | 213.1M | 194.35M | 187.84M | 184.79M | 188.06M | 180.57M | 172.51M | 171.47M | 167.29M | 188.57M | 197.14M | 192.19M |
Operating Income | 15.01M | -228.26K | -9.5M | -15.6M | -17.8M | -8.5M | -5.85M | -16.63M | -8.01M | 4.51M | 23.78M | 32.6M | 19.99M | 13M | 13.48M | 36.88M | 62.67M | 66.73M |
Interest Income | 2.53M | 3.45M | 4.62M | 5.14M | 6.2M | 5.95M | 4.3M | -2.23M | 5.18M | 1.22M | 4.33M | 13.55M | 8.51M | 11.79M | 16.72M | 12.42M | 8.29M | 8.29M |
Pretax Income | 3.59M | -3.3M | -8.13M | -17.53M | -15.74M | -12.65M | -12.7M | -28.06M | -22.09M | -5.92M | 14.99M | 34.71M | 26.34M | 14.13M | 22.31M | 28.48M | 38.1M | 46.17M |
Net Income | -8.24M | -14.09M | -11.79M | -17.37M | -12.88M | -10.36M | -10.15M | -22.05M | -16.42M | -2M | 13.67M | 30.16M | 20.39M | 10.54M | 15.6M | 24.32M | 34.64M | 39.86M |
Selling & General & Admin | 199.84M | 198.07M | 186.24M | 192.45M | 184.3M | 180.73M | 172.59M | 164.35M | 160.93M | 143.98M | 131.82M | 111.16M | 99.87M | 93.75M | 90.16M | 80.48M | 78.37M | 72.9M |
Research & Development | 87.8M | 85.58M | 82.92M | 72.47M | 72.4M | 71.71M | 68.85M | 68.05M | 59.74M | 53.29M | 52.53M | 58.67M | 71.51M | 70.58M | 66.1M | 62.58M | 47.36M | 43M |
Other Expenses | -1.16M | -1.16M | -1.12M | -1.12M | -649K | -22.58M | -22.81M | -21.73M | -22.07M | -14.23M | -14.52M | -16.3M | -16.04M | -2.87M | -2.21M | 6.96M | 7.11M | 7.78M |
Operating Expenses | 289.51M | 285.53M | 271.42M | 264.15M | 256.69M | 230.53M | 218.95M | 210.99M | 198.62M | 183.04M | 169.83M | 153.52M | 155.31M | 161.26M | 153.8M | 151.69M | 134.47M | 125.46M |
Interest Expense | 15.34M | 12.55M | 9.01M | 7.87M | 6.53M | 4.72M | 5.96M | 6M | 5.6M | 6.77M | 5.36M | 5.47M | 5.63M | 5.58M | 5.79M | 5.24M | 22.18M | 21.1M |
Selling & Marketing Expenses | -21.47M | 11.46M | 7.13M | 12.54M | 8.98M | 9.96M | 6.82M | 115.12M | 110.37M | 95.71M | 85.8M | 70.32M | 64.12M | 58.79M | 55.98M | 60.32M | 59.12M | 57.24M |
Cost & Expenses | 325.98M | 320.87M | 306.63M | 301.93M | 295.94M | 267.51M | 251.82M | 235.35M | 217.07M | 199.8M | 187.39M | 169.7M | 174.74M | 181.33M | 173.7M | 174.78M | 158.08M | 149.55M |
Income Tax Expense | 12M | 10.57M | 3.3M | 186.53K | -2.52M | -1.55M | -1.85M | -6.01M | -5.67M | -3.92M | 1.31M | 4.55M | 5.95M | 3.59M | 6.96M | 4.42M | 3.71M | 6.56M |
Shares Outstanding (Basic) | n/a | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 83.05M | 86.53M | 86.53M | 80.25M | 79.76M | 80.13M | 79.76M |
Shares Outstanding (Diluted) | n/a | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 86.53M | 86.53M | 86.53M | 87.64M | 80.13M | 80.13M | 81.95M |
EPS (Basic) | 0.52 | -0.2 | -0.13 | -0.21 | -0.15 | -0.12 | -0.12 | -0.26 | -0.2 | -0.03 | 0.16 | 0.36 | 0.24 | 0.12 | 0.18 | 0.29 | 0.40 | 0.46 |
EPS (Diluted) | 0.42 | -0.2 | -0.13 | -0.21 | -0.15 | -0.12 | -0.12 | -0.26 | -0.21 | -0.04 | 0.15 | 0.35 | 0.24 | 0.11 | 0.18 | 0.29 | 0.40 | 0.46 |
EBITDA | 30.42M | 14.49M | 9.45M | 690.87K | -1.75M | 9.25M | 6.83M | -10.38M | -2.71M | 13.55M | 32.92M | 57.16M | 49.17M | 37.37M | 46.02M | 57.3M | 83.43M | 84.82M |
EBIT | 17.39M | 7.66M | -715K | -9.33M | -11.93M | -10.29M | -9.1M | -25.11M | -16.49M | 854K | 20.34M | 41.23M | 33.01M | 20.82M | 29.6M | 18.17M | 44.73M | 46.25M |
Depreciation & Amortization | 13.03M | 12.74M | 16.08M | 15.93M | 16.09M | 19.54M | 15.93M | 15.34M | 14.39M | 13.3M | 13.19M | 19.18M | 19.42M | 19.8M | 19.67M | 9.68M | 9.96M | 9.13M |